EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Factors Associated With Intraocular Inflammation in Neovascular Age-Related Macular Degeneration Patients Treated With Brolucizumab

Yuto Hashimoto, Satoru Inoda, Hidenori Takahashi, Ryota Takahashi, Hana Yoshida, Yujiro Fujino, Shinichi Sakamoto, Hidetoshi Kawashima, Yasuo Yanagi

Investigative Opthalmology & Visual Science · 2024

DOI: 10.1167/iovs.65.1.8 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Investigative Opthalmology & Visual Science, 2024. Verfasst von Yuto Hashimoto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Jichi Medical University, Tochigi, Japan. Hauptthemen laut MEDLINE: Macular Degeneration, Uveitis, Wet Macular Degeneration. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To identify factors associated with intraocular inflammation (IOI) in patients with neovascular age-related macular degeneration (nAMD) treated with brolucizumab.

Methods

In this prospective observational study, we collected aqueous humor samples from 96 eyes of 96 patients receiving treatment with brolucizumab; IOI subsequently developed in 19 eyes of 19 patients. To identify cytokines upregulated in eyes with subsequent development of IOI, we compared the aqueous humor cytokine levels between the IOI and non-IOI groups. We also collected plasma from 20 patients who developed IOI and 20 age- and sex-matched controls to identify differences in plasma biomarkers and the subfraction of CD4+ cells. Using stepwise variable selection and multivariate binary regression analysis, we developed an algorithm that accurately assessed the likelihood of IOI occurrence.

Results

The IOI group showed elevated aqueous humor levels of P-selectin (584 vs. 324 pg/mL, P = 0.013), TNF-α (0.89 vs. 0.60 pg/mL, P = 0.018), and IL-1α (2.0 vs. 1.4 pg/mL, P = 0.035) compared with the non-IOI group. Serum MMP-9 concentrations were higher in the IOI group than the non-IOI group (18,310 vs. 13,450 pg/mL, P = 0.029). Furthermore, the percentage of Th2 cells was significantly decreased in the IOI compared with the non-IOI group (3.1% vs. 4.2%, P = 0.013). The receiver operating characteristic curves for the optimal models showed an area under the curve ranging from 0.71 to 0.89, indicating good performance.

Conclusions

The combination of elevated concentrations of multiple aqueous humor cytokines and of serum MMP-9 and a lower number of plasma Th2 cells is associated with brolucizumab-related IOI in patients with nAMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macular DegenerationUveitisWet Macular DegenerationHumansAngiogenesis InhibitorsCytokinesInflammationIntravitreal InjectionsMatrix Metalloproteinase 9Prospective StudiesAntibodies, Monoclonal, Humanized

Substanzen

Angiogenesis InhibitorsCytokinesMatrix Metalloproteinase 9brolucizumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Ophthalmology, Jichi Medical University, Tochigi, Japan.
  • Department of Ophthalmology, Japan Community Healthcare Organization Tokyo Shinjuku Medical Center, Tokyo, Japan.
  • Department of Ophthalmology and Micro-Technology, Yokohama City University Medical Center, Yokohama, Japan.
  • The Ophthalmology & Visual Sciences Academic Clinical Program, Duke-NUS Medical School, National University of Singapore, Singapore.

Zitieren

APA

Hashimoto, Y., Inoda, S., Takahashi, H., Takahashi, R., Yoshida, H., Fujino, Y., Sakamoto, S., Kawashima, H., & Yanagi, Y. (2024). Factors Associated With Intraocular Inflammation in Neovascular Age-Related Macular Degeneration Patients Treated With Brolucizumab. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.65.1.8

Vancouver

Hashimoto Y, Inoda S, Takahashi H, Takahashi R, Yoshida H, Fujino Y, et al. Factors Associated With Intraocular Inflammation in Neovascular Age-Related Macular Degeneration Patients Treated With Brolucizumab. Investigative Opthalmology & Visual Science. 2024. doi:10.1167/iovs.65.1.8

BibTeX
@article{Hashimoto2024,
  author = {Hashimoto, Yuto and Inoda, Satoru and Takahashi, Hidenori and Takahashi, Ryota and Yoshida, Hana and Fujino, Yujiro and Sakamoto, Shinichi and Kawashima, Hidetoshi and Yanagi, Yasuo},
  title = {Factors Associated With Intraocular Inflammation in Neovascular Age-Related Macular Degeneration Patients Treated With Brolucizumab},
  journal = {Investigative Opthalmology & Visual Science},
  year = {2024},
  doi = {10.1167/iovs.65.1.8}
}
Kostenlos starten →